| Source: |
| Type: |
| ICAD (inhibitor of caspase-activated DNase, also known as DFFA) ICAD is the physiological inhibitor of CAD, the nuclease responsible for executing DNA fragmentation during apoptosis. • Caspase-mediated cleavage of ICAD is a key regulatory step that unleashes CAD activity during apoptosis. Its dysregulation (either up‐ or down‐regulation) has been linked to altered apoptotic responses, genomic instability, and ultimately clinical outcomes. Either overexpression or underexpression can disrupt this balance: ▪ Overexpression may blunt the full execution of apoptosis in response to stresses (e.g., chemotherapy). ▪ Underexpression may lead to unscheduled or incomplete apoptosis, which in some scenarios might paradoxically fuel genomic instability. |
| 1448- | Bos, | A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells |
| - | in-vitro, | AML, | HL-60 |
| 2776- | Bos, | Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities |
| - | Review, | Var, | NA |
| 3192- | SFN, | Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention |
| - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:877 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid